Correlation of Bridging Therapy (BT) and Lymphodepleting Chemotherapy (LDC) with clinical outcomes in patients (pts) with relapsed/refractory Diffuse Large B-cell Lymphoma (r/r DLBCL) treated with tisagenlecleucelC. Andreadis,C. S. Tam,P. Borchmann,U. Jaeger,J. P. McGuirk,H. Holte,E. K. Waller,S. Jaglowski,M. R. Bishop,S. R. Foley,J. R. Westin,I Fleury,P. J. Ho, S. Mielke,T. Teshima,G. A. Salles,S. J. Schuster,V Bachanova,R. T. Maziarz, V Besien K.,K. Izutsu,N. D. Wagner-Johnston,K. Kato,P. Corradini,R. Tiwari,R. Awasthi, T. Lawniczek,L. K. Eldjerou,M. J. KerstenONCOLOGY RESEARCH AND TREATMENT（2020）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
